Clonmel Prescription
Nintedanib Clonmel
Nintedanib Clonmel is indicated in combination with docetaxel for the treatment of adult patients with locally advanced,
metastatic or locally recurrent non-small cell lung cancer (NSCLC) of adenocarcinoma tumour histology after first-line
chemotherapy.
Active Ingredient:
Nintedanib